Ionic regulation of human basophil releasability. II. Non-releasing basophils are converted into releasing basophils in a low-Na+ medium.
The effects of different extracellular Na+ and Ca2+ concentrations on histamine release from human basophils were investigated. Isosmotic replacement of extracellular Na+ either with choline+, a non-permeant Na+ analogue, or glucose significantly increased spontaneous and anti-IgE-induced histamine release. Basophils from 12 of 49 normal subjects, which were found not to release histamine upon challenge with an optimal dose of anti-IgE in a 135 mM NaCl buffer, were converted into releasing basophils when stimulation with anti-IgE was performed in a low-Na+ medium. The increase in Na+ concentration in the extracellular medium was accompanied by a reduction in the magnitude of basophil response to anti-IgE, which was significantly more pronounced in non-releasers than in releasers (per cent inhibition by 70 mM NaCl 75.5 +/- 3.2 vs 43.5 +/- 9.0, P < 0.01). At higher Na+ concentrations a progressive and almost complete abrogation of histamine release was observed in non-releasers, but not in releasers (maximal per cent inhibition at 140 mM NaCl 97.3 +/- 1.3 vs 50.4 +/- 8.6). The Na+/H+ exchanger monensin had a dose-dependent inhibitory effect on anti-IgE-induced histamine release, and the concentration inhibiting 50% of histamine release was 1.5 x 10(-7) M. When basophils were challenged in the presence of different Na+ and Ca2+ concentrations, it was shown that the two cations have antagonistic effects, which is to say that they down-regulate and upregulate histamine release, respectively. Moreover, the requirement of extracellular Ca2+ was lowered in a low-Na+ medium.(ABSTRACT TRUNCATED AT 250 WORDS)
Tedeschi
A
A
Department of Internal Medicine, University of Milan, Ospedale Maggiore Policlinico, Italy.
Arquati
M
M
Palella
M
M
Milazzo
N
N
Miadonna
A
A
D000293:Adolescent; D000328:Adult; D001491:Basophils / Q000276:immunology / Q000378:metabolism*; D002118:Calcium / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D006632:Histamine / Q000378:metabolism*; D006636:Histamine Release / Q000502:physiology*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008985:Monensin / Q000494:pharmacology; D012964:Sodium / Q000502:physiology*; D015854:Up-Regulation
D007073:Immunoglobulin E; D006632:Histamine; D008985:Monensin; D012964:Sodium; D002118:Calcium